The Food and Drug Administration says it has decided to ... repeat COVID-19 vaccine doses or boosters," Dr. Vinay Prasad, the FDA's new top vaccines official, said in a video posted by the agency ...

Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the HADLIMA™ (adalimumab-bwwd) high- and low-concentration ...

Though Kennedy didn't provide extensive details on how his department plans to completely phase out dyes, a press release from his department stated that the Food and Drug Administration (FDA ...

ROSEMONT, Illinois, May 15 (Reuters) - The U.S. Food and Drug Administration plans to step ... Kennedy Jr., whose agency oversees the FDA, has pledged to tackle chronic illnesses by overhauling ...

Kennedy, Jr., announced that he has directed the Food and Drug Administration (FDA) to undertake a review of its regulations on mifepristone, a safe and effective medication used in most U.S.

Stacey Leasca is an award-winning journalist with nearly two decades of newsroom experience. She is also the co-founder of Be a Travel Writer, an online course for the next generation of travel ...

At the same time, we want more evidence at the U.S. Food and Drug Administration," Prasad told scientists at the FDA during a livestreamed presentation. "We want to know more about what these ...

The Food and Drug Administration uses import alerts to enforce ... Recent modifications to FDA’s import alerts, as posted by the agency, are listed below. Click here to go to the FDA page ...

The Food and Drug Administration announced Tuesday it is ... More & Johnson COVID-19 vaccine on March 6, 2021 in Thornton, Colorado. FDA Commissioner Marty Makary and Vinay Prasad, the agency ...

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

at the US Food and Drug Administration removed thousands of workers, signs are emerging about how the agency’s approach to drug approval may change. The 20% RIF on April 1, which excluded drug ...